David G. Witte

1.8k total citations
56 papers, 1.4k citations indexed

About

David G. Witte is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David G. Witte has authored 56 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 26 papers in Immunology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in David G. Witte's work include Mast cells and histamine (24 papers), Receptor Mechanisms and Signaling (20 papers) and Neuropeptides and Animal Physiology (14 papers). David G. Witte is often cited by papers focused on Mast cells and histamine (24 papers), Receptor Mechanisms and Signaling (20 papers) and Neuropeptides and Animal Physiology (14 papers). David G. Witte collaborates with scholars based in United States, United Kingdom and Netherlands. David G. Witte's co-authors include Timothy A. Esbenshade, Arthur A. Hancock, Thomas R. Miller, Kathleen M. Krueger, Youssef L. Bennani, Betty Yao, Alex M. Nadzan, Marlon Cowart, Gerard B. Fox and Thomas R. Miller and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

David G. Witte

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David G. Witte United States	23	829	636	328	237	222	56	1.4k
Isabelle Berrebi‐Bertrand France	18	922 1.1×	243 0.4×	140 0.4×	101 0.4×	139 0.6×	38	1.2k
Tiffany Runyan Garrison United States	16	1.1k 1.3×	183 0.3×	579 1.8×	61 0.3×	188 0.8×	19	1.6k
Takatoshi Soga Japan	13	773 0.9×	172 0.3×	237 0.7×	32 0.1×	235 1.1×	21	1.5k
Stephanie C. Stotz Canada	23	1.2k 1.4×	65 0.1×	629 1.9×	202 0.9×	145 0.7×	41	1.7k
Chinh Bach United States	12	707 0.9×	160 0.3×	440 1.3×	18 0.1×	143 0.6×	14	1.4k
Donald Button United States	15	555 0.7×	100 0.2×	295 0.9×	109 0.5×	88 0.4×	23	881
Robert J. Mourey United States	18	881 1.1×	88 0.1×	214 0.7×	51 0.2×	98 0.4×	25	1.3k
San‐Hua Fang China	27	859 1.0×	231 0.4×	343 1.0×	29 0.1×	310 1.4×	56	1.8k
Astrid E. Alewijnse Netherlands	23	1.3k 1.5×	191 0.3×	304 0.9×	33 0.1×	217 1.0×	35	1.6k
Mar Lorente Spain	24	955 1.2×	177 0.3×	585 1.8×	36 0.2×	153 0.7×	29	2.8k

Countries citing papers authored by David G. Witte

Since Specialization

Citations

This map shows the geographic impact of David G. Witte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Witte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Witte more than expected).

Fields of papers citing papers by David G. Witte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Witte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Witte. The network helps show where David G. Witte may publish in the future.

Co-authorship network of co-authors of David G. Witte

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Witte. A scholar is included among the top collaborators of David G. Witte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Witte. David G. Witte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cassar, Steven, Nathan R. Rustay, Teresa A. Ellis, et al.. (2010). Comparing levels of biochemical markers in CSF from cannulated and non-cannulated rats. Journal of Neuroscience Methods. 192(2). 249–253. 9 indexed citations

Koenig, John R., Huaqing Liu, Irene Drizin, et al.. (2010). Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: Effects of substitution about the rigidifying ring. Bioorganic & Medicinal Chemistry Letters. 20(6). 1900–1904. 19 indexed citations

Miller, Thomas R., John L. Baranowski, David G. Witte, et al.. (2008). A Robust and High-Capacity [ ³⁵ S]GTP γ S Binding Assay for Determining Antagonist and Inverse Agonist Pharmacological Parameters of Histamine H ₃ Receptor Ligands. Assay and Drug Development Technologies. 6(3). 339–349. 5 indexed citations

Strakhova, Marina I., Gerard B. Fox, Tracy L. Carr, et al.. (2008). Cloning and characterization of the monkey histamine H3 receptor isoforms. European Journal of Pharmacology. 601(1-3). 8–15. 10 indexed citations

Cowart, M. D., Minghua Sun, Chen Zhao, et al.. (2007). A new family of histamine H3 receptor antagonists based on a natural product: discovery, SAR, and properties of the series. Inflammation Research. 56(S1). S47–S48. 2 indexed citations

Krueger, K. M., et al.. (2006). Differences in pharmacological properties of histamine H3 receptor agonists and antagonists revealed at two human H3 receptor isoforms. Inflammation Research. 55(S1). S45–S46. 8 indexed citations

Strakhova, Marina I., et al.. (2006). Differential CNS expression and functional activity of multiple human H3 receptor isoforms. Inflammation Research. 55(S1). S38–S39. 7 indexed citations

Yao, B. B., David G. Witte, Ted R. Miller, et al.. (2005). Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor. Neuropharmacology. 50(4). 468–478. 9 indexed citations

Hancock, Arthur A., Youssef L. Bennani, Eugene N. Bush, et al.. (2004). Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist. European Journal of Pharmacology. 487(1-3). 183–197. 79 indexed citations

10.

Witte, David G., Thomas R. Miller, B. B. Yao, et al.. (2003). In vitro pharmacological properties of two novel non-imidazole H 3 receptor (H 3 R) antagonists. Inflammation Research. 52(0). s45–s46. 1 indexed citations

11.

Witte, David G., Michael E. Brune, Ivan Milicic, et al.. (2002). Modeling of Relationships between Pharmacokinetics and Blockade of Agonist-Induced Elevation of Intraurethral Pressure and Mean Arterial Pressure in Conscious Dogs Treated with α1-Adrenoceptor Antagonists. Journal of Pharmacology and Experimental Therapeutics. 300(2). 495–504. 16 indexed citations

12.

Lin, Chii‐Wann, David G. Witte, Benedetta Bianchi, et al.. (1995). Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.. Molecular Pharmacology. 47(1). 131–139. 36 indexed citations

13.

Bennett, Michael J., Arthur L. Nikkel, Thomas R. Miller, et al.. (1994). CCK-A-Selective Tetrapeptides Containing Lys(N.epsilon.)-Amide Residues: Favorable in vivo and in vitro Effects of N-Methylation at the Aspartyl Residue. Journal of Medicinal Chemistry. 37(11). 1569–1571. 1 indexed citations

14.

Elliott, Richard L., Hana Kopecka, Michael D. Tufano, et al.. (1994). Novel Asp32-Replacement Tetrapeptide Analogs as Potent and Selective CCK-A Agonists. Journal of Medicinal Chemistry. 37(11). 1562–1568. 8 indexed citations

15.

Holladay, Mark W., Hana Kopecka, Thomas R. Miller, et al.. (1994). Tetrapeptide CCK-A Agonists: Effect of Backbone N-Methylations on in vitro and in vivo CCK Activity. Journal of Medicinal Chemistry. 37(5). 630–635. 13 indexed citations

16.

Elliott, Richard L., Hana Kopecka, Michael J. Bennett, et al.. (1994). Tetrapeptide CCK agonists: structure-activity studies on modifications at the N-terminus. Journal of Medicinal Chemistry. 37(2). 309–313. 9 indexed citations

17.

Wu‐Wong, Jinshyun R., William J. Chiou, Scott R. Magnuson, David G. Witte, & Cheng‐Wen Lin. (1993). Identification and characterization of type A endothelin receptors in MMQ cells.. Molecular Pharmacology. 44(2). 285–291. 8 indexed citations

18.

Frail, D E, Arlene M. Manelli, David G. Witte, et al.. (1993). Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization.. Molecular Pharmacology. 44(6). 1113–1118. 36 indexed citations

19.

Shue, Youe‐Kong, Michael D. Tufano, George M. Carrera, et al.. (1993). Double bond isosteres of the peptide bond: Synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs. Bioorganic & Medicinal Chemistry. 1(3). 161–171. 6 indexed citations

20.

Witte, David G., Alex M. Nadzan, Jean Martínez, Marc Rodriguez, & Chun Wel Lin. (1992). Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells. Peptides. 13(6). 1227–1232. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact